Ranibizumab ophthalmic and Tranexamic acid Intravenous
Determining the interaction of Ranibizumab ophthalmic and Tranexamic acid Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: tranexamic acid
Brand name: Cyklokapron, Lysteda
Synonyms: Tranexamic acid, Tranexamic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab ophthalmic-Tranexamic Acid Tablet
- Ranibizumab ophthalmic-Tranexamic Acid Tablets
- Ranibizumab ophthalmic-Tranquil
- Ranibizumab ophthalmic-Transanosil
- Ranibizumab ophthalmic-Transderm-Nitro
- Ranibizumab ophthalmic-Transderm-Scop
- Tranexamic acid Intravenous-Ranitidine
- Tranexamic acid Intravenous-Ranitidine Capsule
- Tranexamic acid Intravenous-Ranitidine Hydrochloride
- Tranexamic acid Intravenous-Ranitidine Injection
- Tranexamic acid Intravenous-Ranitidine Suspension
- Tranexamic acid Intravenous-Ranitidine Syrup